Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.
[read the full story...]
Lisa Burscheidt summarises a recent Cochrane systematic review of Omega-3 fatty acids for depression in adults, which finds a lack of evidence to determine the effects of n-3PUFAs as a treatment for major depressive disorder.
[read the full story...]
Should all molecular research institutes looking at neurodegenerative diseases be replaced by parks, playgrounds and cycle paths? Mark Horowitz highlights a recent systematic review of modifiable risk factors associated with cognition and dementia, which suggests that from a public health perspective, there may be some sense in this idea.
[read the full story...]
Bipolar disorder features as one of the top ten disabling disorders for working age adults. There are numerous risks including suicide, increased mortality and reduced social functioning associated with the disorder. Key to enabling recovery is preventing acute episodes from occurring, with each episode increasing the risk of future ones. Therefore ensuring long-term maintenance treatment [read the full story…]
Drug treatments are commonly used to treat children and young people with attention deficit hyperactivity disorder (ADHD). Methylphenidate and amphetamine are two of the most popular, but these are not effective for all patients and sometimes cause problematic side effects. Children and adolescents with ADHD have been shown to have significantly lower plasma and blood [read the full story…]
Fish oil supplements are big business. The worldwide omega-3 market has recently been valued at around $5 billion with 40% growth predicted between 2010 and 2015. Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: Alpha [read the full story…]
Previous research has highlighted that people with autism spectrum disorders may be deficit in omega-3 fatty acids and that taking supplements may help to improve the symptoms of the condition. This new Cochrane systematic review set out to review the efficacy of omega-3 fatty acids for improving core features of autism spectrum disorder (e.g. social [read the full story…]
